Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DrugCVar: a platform for evidence-based drug annotation for genetic variants in cancer.

Bioinformatics (Oxford, England) - 26 May 2022

Zhang Xiaolong, Qian Zhikai, Wang Ye, Zhang Qingfeng, Yu Kai, Zheng Yongqiang, Liu Zekun, Zhao Qi, Liu Ze-Xian

Abstract excerpt

MOTIVATION: Targeted therapy for cancer-related genetic variants is critical for precision medicine. Although several databases including The Clinical Interpretation of Variants in Cancer (CIViC), The Oncology Knowledge Base (OncoKB), The Cancer Genome Interpreter (CGI) and My Cancer Genome (MCG) provide clinical interpretations of variants in cancer, the clinical evidence was limited and miscellaneous. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Genetic
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Knowledge Bases

Share to Molecular Sequence Annotation

Share to Neoplasms

Share to Precision Medicine

Share to Software

Source

Identifiers

PMID: 35426945
DOI: 10.1093/bioinformatics/btac273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DrugCVar: a platform for evidence-based drug annotation for genetic variants in cancer.PMID 35426945Read ↗

Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation communitySemantic proximity Read ↗

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.Semantic proximity Read ↗

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Semantic proximity Read ↗

The CIViC knowledge model and standard operating procedures for curation and clinical interpretation of variants in cancerSemantic proximity Read ↗

PGMD: a comprehensive manually curated pharmacogenomic database.Semantic proximity Read ↗

Resources for Interpreting Variants in Precision Genomic Oncology ApplicationsSemantic proximity Read ↗

CACSV: a computational web-sever that provides classification for cancer somatic genetic variants from different tissues.Semantic proximity Read ↗

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.Semantic proximity Read ↗

A harmonized meta-knowledgebase of clinical interpretations of cancer genomic variantsSemantic proximity Read ↗

Supporting precision medicine by data mining across multi-disciplines: an integrative approach for generating comprehensive linkages between single nucleotide variants (SNVs) and drug-binding sites.Semantic proximity Read ↗

AVADA Enables Automated Genetic Variant Curation Directly from the Full Text LiteratureSemantic proximity Read ↗

DoCM: a database of curated mutations in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.